Abstract
Rabbits implanted with VX2 carcinoma and treated by cyclic plasma perfusion showed lower weight loss and longer survival than untreated rabbits. The urinary 3‐methylhistidine/creatinine ratio was less elevated in the treated rabbits than in the untreated rabbits. Myoblasts from untreated rabbits with VX2 carcinoma showed lower proliferation than those from normal rabbits, while those from rabbits treated by cyclic plasma perfusion showed intermediate proliferation. Furthermore, the DNA synthesis rate of myoblasts from treated rabbits was much better maintained than in the case of untreated rabbits.
Keywords: Key words, Anemia‐inducing substance, Plasma perfusion, 3‐Methylhistidine, Myoblast, Cancer cachexia
Full Text
The Full Text of this article is available as a PDF (71.3 KB).
REFERENCES
- 1. ) Tisdale , M. J.Cancer cachexia . Anti-Cancer Drugs , 4 , 115 – 125 ( 1993. ). [DOI] [PubMed] [Google Scholar]
- 2. ) Angíles , J. M. , Garcia‐Martinez , C. , Llovera , M. and López‐Soriano , F. J.The role of cytokines in muscle wasting: its relation with cancer cachexia . Med. Res. Rev. , 12 , 637 – 652 ( 1992. ). [DOI] [PubMed] [Google Scholar]
- 3. ) Young , V. R. and Munro , H. N.N‐Methylhistidine (3‐methylhistidine) and muscle protein turnover: an overview . Fed. Proc. , 37 , 2291 – 2300 ( 1978. ). [PubMed] [Google Scholar]
- 4. ) Heber , D. , Chlebowski , R. T. , Ishibashi , D. E. , Herrold , J. N. and Block , J. B.Abnormalities in glucose and protein metabolism in noncachectic lung cancer patients . Cancer Res. , 42 , 4815 – 4819 ( 1982. ). [PubMed] [Google Scholar]
- 5. ) Lundholm , K. , Bennegård , K. , Edén , E. , Svaninger , G. , Emery , P. W. and Rennie , M. J.Efflux of 3‐methylhistidine from the leg in cancer patients who experience weight loss . Cancer Res. , 42 , 4807 – 4811 ( 1982. ). [PubMed] [Google Scholar]
- 6. ) Ishiko , O. , Deguchi , M. , Tatsuta , I. , Naka , K. , Hirai , K. , Nakata , S. , Honda , K. and Sugawa , T.Removal of immuno‐suppressive substance in cancer patients' serum . Jpn. J. Cancer Res. , 81 , 564 – 566 ( 1990. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. ) Deguchi , M. , Ishiko , O. , Hirai , K. , Naka , K. , Tatsuta , I. and Sugawa , T.Studies on pathogenesis of cancer cachexy — partial isolation of anemia‐inducing substance (AIS) and basic study on removal of AIS by plasmapheresis . Adv. Obstet. Gynecol. , 43 , 128 – 137 ( 1991. ) ( in Japanese ). [Google Scholar]
- 8. ) Moss , F. P. and Leblond , C. P.Satellite cells as the source of nuclei in muscles of growing rats . Anat. Rec. , 170 , 421 – 436 ( 1971. ). [DOI] [PubMed] [Google Scholar]
- 9. ) Carlson , B. M.The regeneration of skeletal muscle — a review . Am. J. Anat. , 137 , 119 – 150 ( 1974. ). [DOI] [PubMed] [Google Scholar]
- 10. ) Tajima , Y.“Biological Reference Data Book on Experimental Animals,” p. 96 ( 1989. ). Softscience Co., Ltd. , Tokyo ( in Japanese ). [Google Scholar]
- 11. ) Kagawa , T. , Chikata , E. and Tani , J.In vitro myogenesis of the mononucleate cells derived from regenerating muscles of adult mice . Dev. Biol. , 55 , 402 – 407 ( 1977. ). [DOI] [PubMed] [Google Scholar]
- 12. ) Yaffe , D.Retention of differentiation potentialities during prolonged cultivation of myogenic cells . Proc. Natl. Acad. Sci. USA , 61 , 477 – 483 ( 1968. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. ) Ono , T. , Ohashi , M. and Yago , N.The effect of toxohormone on iron metabolism . Gann , 51 , 213 – 221 ( 1960. ). [PubMed] [Google Scholar]
- 14. ) Fong , Y. , Moldawer , L. L. , Marano , M. , Wei , H. , Barber , A. , Manogue , K. , Tracey , K. J. , Kuo , G. , Fischman , D. A. , Cerami , A. and Lowry , S. F.Cachectin/TNF or IL‐1α induces cachexia with redistribution of body proteins . Am. J. Physiol. , 256 , R659 – R665 ( 1989. ). [DOI] [PubMed] [Google Scholar]
- 15. ) Lönnroth , C. , Moldawer , L. L. , Gelin , J. , Kindblom , L. , Sherry , B. and Lundholm , K.Tumor necrosis factor‐α and interleukin‐1α production in cachectic, tumor‐bearing mice . Int. J. Cancer , 46 , 889 – 896 ( 1990. ). [DOI] [PubMed] [Google Scholar]
- 16. ) Ebisui , C. , Tsujinaka , T. , Morimoto , T. , Kan , K. , lijima , S. , Yano , M. , Kominami , E. , Tanaka , K. and Monden , M.Interleukin‐6 induces proteolysis by activating intracellular proteases (cathepsins B and L, proteasome) in C2C12 myotubes . Clin. Sci. , 89 , 431 – 439 ( 1995. ). [DOI] [PubMed] [Google Scholar]
- 17. ) Brouckaert , P. , Spriggs , D. R. , Demetri , G. , Kufe , D. W. and Fiers , W.Circulating interleukin 6 during a continuous infusion of tumor necrosis factor and interferon γ . J. Exp. Med. , 169 , 2257 – 2262 ( 1989. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. ) Balkwill , F. , Osborne , R. , Burke , F. , Naylor , S. , Talbot , D. , Durbin , H. , Tavernier , J. and Fiers , W.Evidence for tumor necrosis factor/cachectin production in cancer . Lancet , ii , 1229 – 1232 ( 1987. ). [DOI] [PubMed] [Google Scholar]
- 19. ) Nagabhushan , V. S. and Narasinga Rao , B. S.Studies on 3‐methylhistidine metabolism in children with protein‐energy malnutrition . Am. J. Clin. Nutr. , 31 , 1322 – 1327 ( 1978. ). [DOI] [PubMed] [Google Scholar]
- 20. ) Ishiko , O. , Sugawa , T. , Tatsuta , I. , Shimura , K. , Naka , K. , Deguchi , M. and Umesaki , N.Anemia‐inducing substance (AIS) in advanced cancer: inhibitory effect of AIS on the function of erythrocytes and immunocompetent cells . Jpn. J. Cancer Res. (Gann) , 78 , 596 – 606 ( 1987. ). [PubMed] [Google Scholar]
- 21. ) Tatsuta , I. , Ishiko , O. , Naka , K. , Deguchi , M. and Sugawa , T.Studies on the pathogenesis of cancer anemia . Adv. Obstet. Gynecol. , 41 , 293 – 303 ( 1989. ) ( in Japanese ). [Google Scholar]
- 22. ) Naka , K. , Ishiko , O. , Tatsuta , I. , Deguchi , M. and Sugawa , T.Studies on pathogenesis of cancer cachexy — production of AIS and its immunosuppressive effect . Adv. Obstet. Gynecol. , 41 , 305 – 312 ( 1989. ) ( in Japanese ). [Google Scholar]
- 23. ) Honda , K. , Ishiko , O. , Tatsuta , I. , Deguchi , M. , Hirai , K. , Nakata , S. , Sumi , T. , Yasui , T. and Ogita , S.Anemia‐inducing substance from plasma of patients with advanced malignant neoplasms . Cancer Res. , 55 , 3623 – 3628 ( 1995. ). [PubMed] [Google Scholar]
